INSPInspire Medical Systems, Inc.

$68.91-14% 1Y

The financials

Inspire Medical Systems, Inc. by the numbers

Inspire Medical Systems, Inc. (INSP) reported revenue of $201M in Q2 2026 (quarter ended Jun 30, 2026), down 7.6% from the same quarter a year earlier. That came with a gross margin of 85% and net income of $314K (0.2% of revenue). For the full year FY2025, revenue was $912M (+14% year on year) and net income $145M. Its largest region in Q2 2026 was United States at $187M, 93% of the disclosed total, well ahead of Non Us at 6.6%. The next results filing is expected around Nov 2, 2026, the same week as a year ago.

Inspire Medical Systems, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$201M$217M−7.6%
Gross profit$171M$182M−6.0%
Operating income−$514K−$3.3Mn/a
Net income$314K−$3.6Mto a profit
Diluted EPS$0.01−$0.12to a profit
Revenue by region, Q2 2026, as reported to the SEC
GeographicRevenueShare
United States$187M93%
Non Us$13M6.6%

Business segments

Revenue split by geographic segment, from SEC XBRL filings.

Latest period: Jun 2026Total $200.6M (-2.0%)
Non Us grew +34% year on yearUnited States -9.6% year on year
  • United States$187.3Mquarter on quarter -4.2%year on year -9.6%
  • Non Us$13.3Mquarter on quarter +48%year on year +34%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed Aug 3, 2026, SEC EDGAR